drugset / Trial / NCT01855919

A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain

NCT01855919

Phase 3 Completed 458 enrolled Eli Lilly and Company Shionogi · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the efficacy and safety of duloxetine in participants with Chronic Low Back Pain (CLBP).

Timeline

Start
2013-05
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications

No indication recorded.